Related Experiment Video

Updated: May 6, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

6.3K

Regulation of EMT by Notch signaling pathway in tumor progression

Yumei Li, Jia Ma, Xiujuan Qian

  • 1The Cyrus Tang Hematology Center, Jiangsu Institute of Hematology, the First Affiliated Hospital, Soochow University, Suzhou 215123, China. zhiwei@gmail.com.

Current Cancer Drug Targets
|October 31, 2013
PubMed

Insights

The Notch signaling pathway promotes cancer progression by regulating Epithelial-to-Mesenchymal Transition (EMT). Inhibiting Notch can reverse EMT to Mesenchymal-to-Epithelial Transition (MET), offering a potential cancer treatment strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • The Notch signaling pathway is crucial in cellular processes like proliferation, survival, and migration.
  • Notch signaling is implicated in cancer development and progression.
  • Emerging evidence links Notch to Epithelial-to-Mesenchymal Transition (EMT), a key driver of tumor invasion and metastasis.

Purpose of the Study:

  • To review the role of the Notch signaling pathway in regulating EMT.
  • To explore Notch signaling as a therapeutic target in cancer.

Main Methods:

  • Literature review of studies on Notch signaling and EMT.
  • Analysis of mechanisms by which Notch regulates EMT.
  • Summary of strategies to down-regulate Notch signaling.

Main Results:

  • Notch signaling actively regulates EMT, promoting tumor cell invasion and metastasis.
  • Down-regulation of Notch signaling can reverse EMT to Mesenchymal-to-Epithelial Transition (MET).
  • Inhibitors and natural compounds can reduce Notch signaling activity.

Conclusions:

  • Notch signaling's role in EMT is a significant factor in cancer metastasis.
  • Reversing EMT to MET via Notch inhibition is a promising therapeutic avenue for cancer treatment.
  • Targeting Notch signaling offers potential for improved patient outcomes in oncology.

More Related Videos

Stimulation of Notch Signaling in Mouse Osteoclast Precursors08:01

Stimulation of Notch Signaling in Mouse Osteoclast Precursors

Published on: February 28, 2017

7.7K
Induction and Analysis of Epithelial to Mesenchymal Transition10:37

Induction and Analysis of Epithelial to Mesenchymal Transition

Published on: August 27, 2013

38.0K

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.6K
Notch Signaling Pathway03:14

Notch Signaling Pathway

4.9K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
1.8K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.5K